These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31881553)

  • 1. Donecopride, a Swiss army knife with potential against Alzheimer's disease.
    Rochais C; Lecoutey C; Hamidouche K; Giannoni P; Gaven F; Cem E; Mignani S; Baranger K; Freret T; Bockaert J; Rivera S; Boulouard M; Dallemagne P; Claeysen S
    Br J Pharmacol; 2020 May; 177(9):1988-2005. PubMed ID: 31881553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.
    Lecoutey C; Hedou D; Freret T; Giannoni P; Gaven F; Since M; Bouet V; Ballandonne C; Corvaisier S; Malzert Fréon A; Mignani S; Cresteil T; Boulouard M; Claeysen S; Rochais C; Dallemagne P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3825-30. PubMed ID: 25157130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatments with a 5-HT
    Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
    Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer's Disease.
    Maiti P; Manna J; Burch ZN; Flaherty DB; Larkin JD; Dunbar GL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
    J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
    Jürgenson M; Zharkovskaja T; Noortoots A; Morozova M; Beniashvili A; Zapolski M; Zharkovsky A
    J Pharm Pharmacol; 2019 Nov; 71(11):1695-1705. PubMed ID: 31531878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.
    Chen J; Zhang T; Jiao S; Zhou X; Zhong J; Wang Y; Liu J; Deng J; Wang S; Xu Z
    J Alzheimers Dis; 2017; 59(3):941-949. PubMed ID: 28697556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying treatment with I
    Vasilopoulou F; Rodríguez-Arévalo S; Bagán A; Escolano C; Griñán-Ferré C; Pallàs M
    Br J Pharmacol; 2021 Aug; 178(15):3017-3033. PubMed ID: 33817786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease.
    Mirzaei N; Mota BC; Birch AM; Davis N; Romero-Molina C; Katsouri L; Palmer EOC; Golbano A; Riggall LJ; Nagy I; Tyacke R; Nutt DJ; Sastre M
    Br J Pharmacol; 2021 Feb; 178(3):654-671. PubMed ID: 33140839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.